What’s changing in healthcare Market Research salaries in 2026

The first article in a wider series on salary benchmarking strategies in the UK healthcare market research and business intelligence sector. Associate Director Matt Goldrick explores the recent salary stabilisation in healthcare market research against our 2026 salary data.

“For the past few years, hiring in the Life Sciences insight and consultancy space has felt like trying to plan a route while the road kept moving. The post-pandemic period brought sharp salary inflation, aggressive counteroffers, and a real willingness among employers to bet on potential over proven impact. If you were building a team through 2021 and 2022, you know exactly what I mean.”

That period is over. Our latest market research, drawn from survey responses across specialist Life Sciences market research consultancies alongside intelligence from our own candidate database, points to a market that has entered a genuinely different phase: one of stabilisation and maturity.

For employers, this is good news, but it also changes the rules.

Our benchmarking data paints a more stabilised picture

The sharp inflation seen across 2021 and 2022 has clearly levelled off. Compensation across the sector is now more structured and more consistent than it was even eighteen months ago, and it is increasingly tied to demonstrable impact rather than assumed potential.

Our consolidated benchmarking data shows a well-defined pay structure at every level, from Research Executive through to Senior Research Director and above. Figures are presented in GBP, reflecting the primarily UK-based survey sample this data is drawn from:

What stands out is how tightly organisations cluster around these midpoints at junior and mid-levels. The variation only really opens up from Associate Director upward, where salary starts to reflect commercial contribution and client ownership rather than title alone.

We also found very limited evidence of regional salary variation. Only one respondent in our entire survey specifically referenced regional pay differences, which tells you how national, and increasingly international, talent benchmarking has become in this sector.

There’s been a shift from potential to proven impact

The more important story here isn’t really about the numbers. It’s about how hiring decisions are being made.

Compared to the immediate post-pandemic period, far fewer organisations are willing to take a chance on potential alone. Return on investment is now paramount in every hire we see. That shows up in three consistent ways:

• Greater emphasis on demonstrable commercial contribution over years of experience alone
• More measured, performance-driven hiring timelines, replacing the speed-at-all-costs approach of 2021 and 2022
• Closer alignment between new hires and specific business-critical needs, rather than general capability building

What this means for those who are looking to hire in healthcare market research

A stabilised market means the tools of competition have changed. Salary inflation is no longer a realistic lever for winning talent, because candidates and employers alike have recalibrated their expectations around what fair compensation actually looks like.

That has real implications for how you approach hiring this year:

• Benchmark against the core range for the role, not the highest figure you have heard about. Our data shows the highest salary points at every level are consistently outliers driven by unusual role scope, not market norms.
• Be precise about what the role actually requires in terms of commercial impact. Candidates are being hired against clearer expectations now, and vague job specs will cost you time.
• Recognise that differentiation increasingly happens outside of base salary. We will be covering exactly where that competitive advantage now lives in the next piece in this series.

If you are reviewing your compensation structure this year or benchmarking a specific hire, I am always happy to talk through where your offering sits against the current market.

Data sourced from Carrot Life Sciences’s Market Research Salary and Benefits Report. Survey respondents include specialist Life Sciences market research consultancies, multi-sector agencies, and PE/VC-backed and independently owned firms of varying scale. For enquiries about the report, contact Matt Goldrick at Carrot Life Sciences.

Looking to hire within Pharma Market Research, Business Intelligence & Consulting?

As salary bands converge and benefits packages become increasingly aligned, the difference between securing top talent and losing them to a competitor often comes down to strategy, speed and market knowledge.

At Carrot Life Sciences, we work exclusively across Pharma, Biotech and MedTech, giving our clients access to a deep, pre-qualified network of professionals across insight and consultancy, from Research Executive through to Senior Director.

Whether you’re scaling a team, replacing a critical hire or benchmarking your offering against the market, our specialist knowledge, market intelligence and established networks help you move quickly and hire with confidence.

In a more competitive talent market, having the right insight and connections can make all the difference.

Matt Goldrick

Associate Director